（派特灵实验室） （中国HPV防治方案持续获得国际关注） 派特灵聚焦HPV转阴率，立足感染源头防治 据了解，派特灵长期以来始终将转阴率作为品牌研发与服务的重点。相较于HPV病毒可能引发的各类疾病，品 牌更专注于从感染源头进行干预。在持续优化产品转阴效果的同时，派特灵也积极探索应用场景的拓展。近年 来，品牌联合多家医院与临床专家，开展中西医结合防治路径的探索，一方面依托现代医学的疫苗与筛查体 系，另一方面发挥中医药"标本兼治"的特色，并结合其具有剥脱病毒寄生细胞等作用等专利技术，为临床医生 和感染者提供更多选择。 新年伊始，企业纷纷公布年度发展规划。近日，中药制剂品牌派特灵宣布，新一年将围绕"提升HPV转阴率"这 一核心目标，全面优化服务质量。该品牌在HPV病毒防治领域已有三十余年积累，随着HPV及宫颈癌防治知识 普及，其相关工作日益受到公众关注，并在国际学术会议上作为"中国方案"得到多国专家学者的研讨。 派特灵聚焦HPV转阴率，助力补全防治链路 根据规划，新一年派特灵在科研方面的投入，除持续优化产品体验与开发潜力外，还将着力于助力弥补HPV感 染防治链条中的薄弱环节，例如疫苗保护不全、筛查不及时、感染者心理负 ...

Group 1 - The 13th China Cervical Cancer Prevention Engineering Academic Annual Conference was held in Shanghai, focusing on key issues such as cervical cancer prevention, basic research, HPV vaccines, screening, and treatment [1][2] - The conference theme was "Precise Prevention and Treatment, Integrated Innovation - Accelerating the Elimination of Cervical Cancer," aiming to enhance gynecological diagnosis and treatment levels in grassroots medical institutions [2][3] - The "90-70-90" cervical cancer prevention target was highlighted, indicating the need for continued efforts to explore optimal prevention paths suitable for China's national conditions [2][3] Group 2 - The Pat Bio Group, a subsidiary of Pat Ling, won the "Social Responsibility Award" at the conference, marking its continuous recognition for over thirty years in the field [1][3] - The conference served as a significant platform for summarizing and exchanging annual viewpoints on cervical cancer and HPV prevention, linking social and medical forces, and integrating advantages from different disciplines [3] - Emphasis was placed on breaking down disciplinary barriers and fostering innovative concepts in cervical cancer prevention, aligning with technological advancements [3]

Group 1 - The trend of HPV infections is increasingly affecting younger populations, challenging the perception that HPV is primarily a concern for older individuals [1][4][6] - Studies indicate that cervical cancer incidence is rising among women aged 25-45, particularly among those born in the 1980s and 1990s, with a notable peak in HPV infections occurring between the ages of 17-24 [4][6] - The prevalence of HPV infections among young males also shows a dual peak distribution, with infection rates of 47.6% for ages 18-24 and 44.51% for ages 40-44, highlighting a significant transmission risk [4][6] Group 2 - Experts recommend proactive measures such as vaccination, regular screenings, and maintaining a healthy lifestyle to enhance immunity against HPV [6][7] - It is emphasized that HPV infection does not equate to disease, and there is no need for excessive fear regarding HPV [7] - Traditional Chinese medicine, including herbal formulations, is suggested as a viable intervention for HPV infections, providing alternatives for those apprehensive about surgical options [6][7]